Molbio Diagnostics Limited (NSE:MOLBIO)

Market Cap	123.44B
Revenue (ttm)	14.46B +41.7%
Net Income	1.67B
EPS	14.77
Shares Out	112.76M
PE Ratio	74.12
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	980,909
Open	1,153.95
Previous Close	1,144.15
Day's Range	1,077.50 - 1,156.10
52-Week Range	807.00 - 1,264.60
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About Molbio Diagnostics

Molbio Diagnostics Limited, a point-of-care diagnostics company, provides healthcare technologies to diagnose infectious and non-communicable diseases. It manufactures and sells chip based diagnostic devices, chips and reagents, X-ray equipment's, and single/dual detectors. It also offers disposable POCT devices, which includes dengue, malaria, and COVID-19 tests; Tabletop analysers, a portable machine that are used to perform molecular or immunodiagnostic tests to detect infectious diseases, such as tuberculosis, human papillomavrus, STIs, and...

• Industry: Medical - Specialties
• Sector: Healthcare
• Founded: 2000
• Employees: 1,225
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: MOLBIO

Financial Performance

In fiscal year 2026, Molbio Diagnostics's revenue was 14.46 billion, an increase of 41.68% compared to the previous year's 10.20 billion. Earnings were 1.67 billion, an increase of 14.81%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Aug 28, 2026

Data Sources Report a data error